Total number with abnormal karyotype

Diagnosis
Total
Cases.
Total number tested
for karyotype (%)
Total number with
abnormal karyotype (%)
Abnormal cytogenetic findings
SM-MPN
SM-MPN
(FIP1L1PDGFRA+)
55
12
44 (80)
10 (83)
8 (18)
2 (20)
47, XXY
SM-MPN
(Other)
43
34 (79)
6 (18)
46,XY,add[3](q13.2) (3q deletion)
46,XY, t(1;7)
47,XY,+8
47,XY,+8
46,XXY,-17
48, XY, +8, +11
46,XX,del(20)(q11.2q13.1)
SM-MDS
28
22 (79)
9 (41)
47,XY,+8
46, XY, del(20) (q11.2q13.1)
45, XX, -7
47,XY,+8[3]/47,X,-Y,+8,+8[3]/48,X,-Y,+8,+8,+21[12]/49-51,X,Y,+8,+8,+13,+21[cp2]
46,XX, del(5q)
45,XY,-7
51, XY, +6,+8,+10,+15,+19
46,XX,t(15;19)(q22;q13.1)
46,XY,del(5)(q31q33),add(8)(p21)[3]/51,idem,+3,+8,+10,+14, +19,add(21)(q22)[17]
SM-CMML
36
32 (89)
8 (25)
47,XY,+8
46,XY,i(14)(q10)
46,XY,del(13q)
46,XY,i(17q)
48,XX,+4, +10
45,XY,-7
46, XY, inv(5) (p13q13)
46, XY, del(13)(q12q22)
SM-AL
4
4 (100)
4 (100)
47,XY,+6
46,XY,del(5) (q32q35)
45, XY, -7
46,XY,add(2)(p11.2),add(5)(p13),del(7)(q22q32),add(16)(p11.2)
AL indicates acute leukemia; CMML, chronic myelomonocytic leukemia; MDS, myelodysplastic syndrome; and MPN, myeloproliferative neoplasm